Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Agios Pharm

AGIO
Current price
29.53 USD +0.26 USD (+0.89%)
Last closed 29.43 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 658 308 608 USD
Yield for 12 month +30.72 %
1Y
3Y
5Y
10Y
15Y
AGIO
21.11.2021 - 28.11.2021

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Address: 88 Sidney Street, Cambridge, MA, United States, 02139

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

42.8 USD

P/E ratio

Dividend Yield

Current Year

+26 823 000 USD

Last Year

+14 240 000 USD

Current Quarter

+7 103 000 USD

Last Quarter

+7 399 000 USD

Current Year

+17 319 000 USD

Last Year

+12 536 000 USD

Current Quarter

+5 114 000 USD

Last Quarter

+6 766 000 USD

Key Figures AGIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -384 864 000 USD
Operating Margin TTM -1496.23 %
PE Ratio
Return On Assets TTM -22.49 %
PEG Ratio
Return On Equity TTM -36.83 %
Wall Street Target Price 42.8 USD
Revenue TTM 26 823 000 USD
Book Value 14.5 USD
Revenue Per Share TTM 0.48 USD
Dividend Share
Quarterly Revenue Growth YOY 64.8 %
Dividend Yield
Gross Profit TTM 12 536 000 USD
Earnings Share -6.33 USD
Diluted Eps TTM -6.33 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AGIO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AGIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AGIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 2.4655
Enterprise Value Revenue 35.5852
Price Sales TTM 61.8241
Enterprise Value EBITDA -2.4801
Price Book MRQ 2.0461

Financials AGIO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AGIO

For 52 weeks

19.8 USD 35.5 USD
50 Day MA 28.88 USD
Shares Short Prior Month 6 850 350
200 Day MA 25.43 USD
Short Ratio 9.54
Shares Short 6 601 368
Short Percent 11.89 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds


M

MDAXEX

207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics